Amicus Therapeutics is a leading biotechnology company based in Cranbury Twp, NJ, specializing in the development of advanced therapies for rare genetic diseases. With a strong commitment to patient advocacy and access to medicines, Amicus leverages innovative technology platforms to create treatments for devastating rare diseases.
Through their extensive pipeline of programs and clinical trials, Amicus aims to provide hope and improved quality of life for individuals living with conditions such as Fabry Disease, Pompe Disease, and Batten Disease. Their dedication to rare disease communities is evident in their patient advisory boards and the inspiring stories of individuals living with these conditions worldwide.
Generated from the website